IKBKB Antikörper
-
- Target Alle IKBKB Antikörper anzeigen
- IKBKB (Inhibitor of kappa Light Polypeptide Gene Enhancer in B-Cells, Kinase beta (IKBKB))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IKBKB Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB)
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of IKBKB expressed in E. coli.
- Klon
- 10A2
- Isotyp
- IgG1
- Top Product
- Discover our top product IKBKB Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
-
Cobrotoxin inhibits NF-kappa B activation and target gene expression through reaction with NF-kappa B signal molecules." in: Biochemistry, Vol. 44, Issue 23, pp. 8326-36, (2005) (PubMed).
: "Activation of nuclear transcription factor-kappa B is associated with the induction of inhibitory kappa B kinase-beta and involves differential activation of protein kinase C and protein tyrosine ..." in: Neuroscience letters, Vol. 340, Issue 2, pp. 139-42, (2003) (PubMed).
: "IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin." in: The Journal of biological chemistry, Vol. 274, Issue 46, pp. 32655-61, (2000) (PubMed).
: "Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding." in: The New England journal of medicine, Vol. 340, Issue 13, pp. 988-93, (1999) (PubMed).
: "
-
Cobrotoxin inhibits NF-kappa B activation and target gene expression through reaction with NF-kappa B signal molecules." in: Biochemistry, Vol. 44, Issue 23, pp. 8326-36, (2005) (PubMed).
-
- Target
- IKBKB (Inhibitor of kappa Light Polypeptide Gene Enhancer in B-Cells, Kinase beta (IKBKB))
- Andere Bezeichnung
- IKBKB (IKBKB Produkte)
- Hintergrund
-
Description: IKBKB(Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, also called IKK2/IKKB), is a member of the IKK complex which is composed of IKK-alpha, IKK-beta, IKK-gamma and IKAP. Phosphorylation of I-Kappa-B on a serine residue by the IKK complex frees NF-kB from I-Kappa-B and marks it for degradation via ubiquination. IKK-beta has been shown to activate NF-kB and phosphorylate IKB-alpha and beta. Phosphorylation of 2 sites at the activation loop of IKK-beta is essential for activation of IKK by TNF and IL1. Once activated, IKK-beta autophosphorylates which in turn decreases IKK activity and prevents prolonged activation of the inflammatory response. Additionally, IKK-beta activity can also be regulated by MEKK-1.
Aliases: IKBKB
- Molekulargewicht
- 43 kDa
- Gen-ID
- 3551
- HGNC
- 3551
- Pathways
- NF-kappaB Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Production of Molecular Mediator of Immune Response, Hepatitis C, Toll-Like Receptors Cascades, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
-